{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:24:18Z","timestamp":1787250258639,"version":"build-2736575974"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The coexistence of tuberculosis (TB) and type 2 diabetes mellitus (T2DM) poses an emerging public health challenge, especially in high-TB-burden settings such as Peru. This comorbidity has been associated to unfavorable clinical outcomes and a higher frequency of drug-resistant TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To estimate the prevalence of resistance to first-line antituberculosis drugs and identify factors associated with multidrug resistance tuberculosis (MDR-TB) among patients with T2DM and pulmonary TB treated at a public hospital in Lima, Peru.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted using secondary data from 130 adults with T2DM and microbiologically confirmed pulmonary TB treated at a Peruvian hospital between 2015 and 2019. Drug susceptibility results were categorized as susceptible, monoresistant, polyresistant, or MDR-TB. Factors associated with MDR and resistance to at least one first-line drug were evaluated using Poisson regression models with robust variance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of resistance to at least one first-line drug was 34.6%, and the prevalence of MDR-TB was 21.5%. The most frequent resistances were to isoniazid (28.4%) and rifampicin (26.2%). In the multivariable analysis, age 40\u201349 years (aPR\u2009=\u20092.99; 95% CI: 1.00\u20138.97) and age 70\u201385 years (aPR\u2009=\u20094.13; 95% CI: 1.16\u201314.7) and were independently associated with MDR-TB. Furthermore, a diabetes duration of at least 5 years was associated with resistance to at least one drug (aPR\u2009\u2248\u20092.1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A high prevalence of drug resistance, including MDR-TB was observed among patients with T2DM and pulmonary TB. Older age and longer duration of diabetes were associated with bacterial resistance in the adjusted analysis. These findings underscore the importance of considering diabetes-related clinical characteristics when evaluating drug resistance patterns in patients with tuberculosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0337152","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T17:30:48Z","timestamp":1787247048000},"page":"e0337152","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["High prevalence of resistance to first-line drugs and multidrug resistance in patients with tuberculosis and type 2 diabetes mellitus at a referral hospital in Peru"],"prefix":"10.1371","volume":"21","author":[{"given":"Sergio","family":"Barboza-Panaifo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Erazo-C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nallely V.","family":"Chapo\u00f1an-Agip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabell","family":"Tenorio-Quispe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1947-7736","authenticated-orcid":true,"given":"Marlon","family":"Yovera-Aldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"3","key":"pone.0337152.ref001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001721","article-title":"Has the DOTS strategy improved case finding or treatment success? An empirical assessment","volume":"3","author":"Z Obermeyer","year":"2008","journal-title":"PLoS One"},{"key":"pone.0337152.ref002","doi-asserted-by":"crossref","first-page":"100480","DOI":"10.1016\/j.jctube.2024.100480","article-title":"Tuberculosis in South Asia: A regional analysis of burden, progress, and future projections using the global burden of disease (1990-2021)","volume":"37","author":"V Kumar","year":"2024","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"1","key":"pone.0337152.ref003","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40249-024-01247-8","article-title":"Further analysis of tuberculosis in eight high-burden countries based on the Global Burden of Disease Study 2021 data","volume":"13","author":"H Lv","year":"2024","journal-title":"Infect Dis Poverty"},{"key":"pone.0337152.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15212\/ZOONOSES-2024-0061","article-title":"Decoding the WHO Global Tuberculosis Report 2024: A critical analysis of global and Chinese key data","volume":"5","author":"Z Chen","year":"2025","journal-title":"Zoonoses"},{"key":"pone.0337152.ref005","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1186\/s12889-024-20664-w","article-title":"Global, regional, and national burden of tuberculosis and attributable risk factors for 204 countries and territories, 1990\u20132021: a systematic analysis for the Global Burden of Diseases 2021 study","volume":"24","author":"H Yang","year":"2024","journal-title":"BMC Public Health"},{"key":"pone.0337152.ref006","first-page":"100963","article-title":"Impact of strategic public health interventions to reduce tuberculosis incidence in Brazil: a Bayesian structural time-series scenario analysis","volume":"41","author":"K Villalva-Serra","year":"2024","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"pone.0337152.ref007","article-title":"Time trend, social vulnerability, and identification of risk areas for tuberculosis in Brazil: An ecological study","volume":"17","author":"JPS de Paiva","year":"2022","journal-title":"PLoS One"},{"key":"pone.0337152.ref008","volume-title":"An\u00e1lisis de la situaci\u00f3n epidemiol\u00f3gica de la tuberculosis en DIRIS Lima Este 2024","author":"Ministerio de Salud (MINSA)","year":"2024"},{"issue":"4","key":"pone.0337152.ref009","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/322777","article-title":"The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru","volume":"184","author":"PG Su\u00e1rez","year":"2001","journal-title":"J Infect Dis"},{"issue":"7","key":"pone.0337152.ref010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001675","article-title":"Defining catastrophic costs and comparing their importance for adverse tuberculosis outcome with multi-drug resistance: a prospective cohort study, Peru","volume":"11","author":"T Wingfield","year":"2014","journal-title":"PLoS Med"},{"issue":"10284","key":"pone.0337152.ref011","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(20)32578-2","article-title":"The escalating tuberculosis crisis in central and South American prisons","volume":"397","author":"KS Walter","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"pone.0337152.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237534","article-title":"Unfavorable outcomes to second-line tuberculosis therapy among HIV-infected versus HIV-uninfected patients in sub-Saharan Africa: A systematic review and meta-analysis","volume":"15","author":"D Edessa","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"pone.0337152.ref013","doi-asserted-by":"crossref","first-page":"245","DOI":"10.15446\/revfacmed.v68n2.71715","article-title":"Distribuci\u00f3n geogr\u00e1fica y factores de riesgo de tuberculosis multidrogorresistente en el centro de Per\u00fa","volume":"68","author":"R Montalvo-Otivo","year":"2020","journal-title":"Rev Fac Med"},{"issue":"4","key":"pone.0337152.ref014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152933","article-title":"Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru","volume":"11","author":"L Villegas","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"pone.0337152.ref015","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"CY Jeon","year":"2008","journal-title":"PLoS Med"},{"issue":"1","key":"pone.0337152.ref016","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.12762","article-title":"Influence of diabetes mellitus on immunity to human tuberculosis","volume":"152","author":"P Kumar Nathella","year":"2017","journal-title":"Immunology"},{"issue":"1","key":"pone.0337152.ref017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13098-025-01844-z","article-title":"Prevalence of diabetes and prediabetes in Peru: a systematic review and meta-analysis","volume":"17","author":"VJ Vera-Ponce","year":"2025","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"pone.0337152.ref018","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1080\/07853890.2022.2085318","article-title":"Incidence and prevalence of pulmonary tuberculosis among patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"54","author":"Q Wu","year":"2022","journal-title":"Ann Med"},{"issue":"6","key":"pone.0337152.ref019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2012.12.029","article-title":"Clinical characteristics, drug resistance, and treatment outcomes among tuberculosis patients with diabetes in Peru","volume":"17","author":"MJ Magee","year":"2013","journal-title":"Int J Infect Dis"},{"key":"pone.0337152.ref020","unstructured":"Servicio Galego de Sa\u00fade (SERGAS). Epidat 4.2. SERGAS. 2016. https:\/\/www.sergas.es\/saude-publica\/epidat-4-2?idioma=es"},{"key":"pone.0337152.ref021","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tube.2017.01.006","article-title":"The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes","volume":"103","author":"LM Perez-Navarro","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"pone.0337152.ref022","first-page":"11","article-title":"Influence of Diabetes Mellitus on the Development of Multi Drug Resistant-Tuberculosis in Yogyakarta","volume":"50","author":"AMI Saktiawati","year":"2018","journal-title":"Acta Med Indones"},{"key":"pone.0337152.ref023","doi-asserted-by":"crossref","first-page":"777000","DOI":"10.3389\/fpubh.2021.777000","article-title":"Epidemiological Characteristics and Their Influencing Factors Among Pulmonary Tuberculosis Patients With and Without Diabetes Mellitus: A Survey Study From Drug Resistance Surveillance in East China","volume":"9","author":"Q Wu","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"pone.0337152.ref024","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1186\/s12879-022-07831-3","article-title":"Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus","volume":"22","author":"S Li","year":"2022","journal-title":"BMC Infect Dis"},{"key":"pone.0337152.ref025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2020.05.080","article-title":"A novel risk factor for predicting anti-tuberculosis drug resistance in patients with tuberculosis complicated with type 2 diabetes mellitus","volume":"97","author":"M Lyu","year":"2020","journal-title":"Int J Infect Dis"},{"key":"pone.0337152.ref026","doi-asserted-by":"crossref","first-page":"1303338","DOI":"10.3389\/fendo.2024.1303338","article-title":"Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?","volume":"15","author":"V Aravindhan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"pone.0337152.ref027","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fimmu.2020.01582","article-title":"The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System","volume":"11","author":"G Daryabor","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"pone.0337152.ref028","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/cid\/ciae329","article-title":"Drug Exposure and Treatment Outcomes in Patients With Multidrug-Resistant Tuberculosis and Diabetes Mellitus: A Multicenter Prospective Cohort Study From China","volume":"79","author":"Y Zhu","year":"2024","journal-title":"Clin Infect Dis"},{"key":"pone.0337152.ref029","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/JMDH.S510247","article-title":"Glycemic Profile and Clinical Treatment in Patients with Diabetes Mellitus-Tuberculosis: An Update Scoping Review","volume":"18","author":"S Rissaadah","year":"2025","journal-title":"J Multidiscip Healthc"},{"issue":"1","key":"pone.0337152.ref030","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1186\/s12879-023-08765-0","article-title":"Diabetes mellitus affects the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis","volume":"23","author":"G Xu","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pone.0337152.ref031","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12902-022-01133-0","article-title":"Non-adherence to medication and associated factors among type 2 diabetes patients at Clinique Medicale Fraternite, Rwanda: a cross-sectional study","volume":"22","author":"D Murwanashyaka J de","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"pone.0337152.ref032","doi-asserted-by":"crossref","first-page":"113","DOI":"10.22159\/ajpcr.2024v17i7.50922","article-title":"An observational study on the outcome of antitubercular and antidiabetic therapy in patients of tuberculosis with diabetes mellitus as comorbidity","author":"J Mistry","year":"2024","journal-title":"Asian J Pharm Clin Res"},{"issue":"2","key":"pone.0337152.ref033","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/cid\/cix819","article-title":"Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment","volume":"66","author":"NR Degner","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pone.0337152.ref034","doi-asserted-by":"crossref","first-page":"240","DOI":"10.21522\/TIJPH.2013.11.02.Art023","article-title":"Impact of Lifestyle Change Intervention on Tuberculosis Treatment Outcome in Tuberculosis Patients with Diabetes Mellitus Comorbidity in South West Nigeria","volume":"11","author":"IU Godwin","year":"2023","journal-title":"TIJPH"},{"key":"pone.0337152.ref035","doi-asserted-by":"crossref","first-page":"101118","DOI":"10.1016\/j.cegh.2022.101118","article-title":"Daily monitoring of diabetic treatment amongst TB-DM patients under NTEP: Does it improve the treatment outcomes?","volume":"17","author":"P Udaykumar","year":"2022","journal-title":"Clinical Epidemiology and Global Health"},{"key":"pone.0337152.ref036","doi-asserted-by":"crossref","first-page":"1244450","DOI":"10.3389\/fpubh.2023.1244450","article-title":"The impact of diabetes mellitus on the emergence of multi-drug resistant tuberculosis and treatment failure in TB-diabetes comorbid patients: a systematic review and meta-analysis","volume":"11","author":"AU Rehman","year":"2023","journal-title":"Front Public Health"},{"issue":"1","key":"pone.0337152.ref037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297342","article-title":"Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines","volume":"19","author":"T Yamanaka","year":"2024","journal-title":"PLoS One"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T17:30:56Z","timestamp":1787247056000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0337152"}},"subtitle":[],"editor":[{"given":"Frederick","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0337152","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}